---
figid: PMC9467758__OMCL2022-9029544.005
pmcid: PMC9467758
image_filename: OMCL2022-9029544.005.jpg
figure_link: /pmc/articles/PMC9467758/figure/fig5/
number: Figure 5
figure_title: ''
caption: CBR-5884 exerts antitumor effect through activating ROS/Wnt/β-catenin pathway.
  PHGDH, β-catenin, c-myc, Cyclin D1, PCNA, Bcl2, BAX, E-caderin, N-cadherin, vimentin,
  and Snail expression level after treatment of different concentration of CBR-5884
  or CBR-5884 with or without NAC.
article_title: PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression
  via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib.
citation: Xiaocui Zhang, et al. Oxid Med Cell Longev. 2022;2022:9029544.
year: '2022'

doi: 10.1155/2022/9029544
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
